In spite of a recent House hearing on pharmacy benefit managers, there is little reason to expect that Congress will enact legislation to curb their practices. In this Bloomberg BNA Pharmaceutical Law & Industry Report article, James Burns comments on the proposed legislation and predicts it will not be enacted into law.
"Community pharmacists have repeatedly maintained that PBMs have utilized their size in anticompetitive ways, reducing the ability of community pharmacists to compete with them," said Mr. Burns. "Earlier this year, legislation on this issue was introduced (H.R. 244), but the legislation has not progressed. Notwithstanding last week's hearing, and the not-insubstantial number of co-sponsors for the bill (roughly 30), there is little reason to expect that the proposed legislation will be enacted into law this Congress."
Read the Article (Subscription required)